SCHEMBL5720940

SCHEMBL5720940

CCCOC(=O)CC(N)c1ccccc1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
LMNA P02545 1/20 0.41
TSHR P16473 3/20 0.41
MAPK1 P28482 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
KDM4E B2RXH2 2/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
ESR1 P03372 1/20 0.37
CHRM1 P11229 1/20 0.37
SLC6A2 P23975 1/20 0.37
KDR P35968 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRB2 P47870 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5720912 0.87 MAPK1 (0.47) ALDH1A1LMNATSHRMAPK1KDM4E
SCHEMBL5720915 0.84 ALDH1A1 (0.41) ALDH1A1LMNATSHRMAPK1KDM4E
SCHEMBL5720865 0.84 ALDH1A1 (0.41) ALDH1A1LMNATSHRMAPK1KDM4E
SCHEMBL5720819 0.84 ALDH1A1 (0.41) ALDH1A1LMNATSHRMAPK1SMN1; SMN2
SCHEMBL5720854 0.84 POLB (0.44) ALDH1A1LMNAMAPK1KDM4ESMN1; SMN2
SCHEMBL5720970 0.84 CASP1 (0.47) ALDH1A1LMNATSHRMAPK1MEN1
SCHEMBL5720992 0.82 CNR1 (0.43) ALDH1A1MAPK1HPGDTOP2A
SCHEMBL5720994 0.81 MAPK1 (0.48) ALDH1A1LMNAMAPK1TDP1GRM6
SCHEMBL5720971 0.80 LMNA (0.49) ALDH1A1LMNACHRM1TOP2AGAA
SCHEMBL1138690 0.80 LMNA (0.49) ALDH1A1LMNACHRM1TOP2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060178433-A1 3-Amino-3-arylpropionic acid n-alkyl esters, process for production thereof, and process for production of optically active 3-amino-3-arylpropionic acids and esters of the antipodes thereto UBE INDUSTRIES, LTD. (JP) 2006-08-10 US disclosed
EP-1621529-A1 3-AMINO-3-ARYLPROPIONIC ACID n-ALKYL ESTERS, PROCESS FOR PRODUCTION THEREOF, AND PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE 3-AMINO-3-ARYLPROPIONIC ACIDS AND ESTERS OF THE ANTIPODES THERETO Ube Industries, Ltd. (JP) 2006-02-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060178433-A1 3-Amino-3-arylpropionic acid n-alkyl esters, process for production thereof, and process for production of optically active 3-amino-3-arylpropionic acids and esters of the antipodes thereto ALAD, ARSA, ALDH7A1 ALDH1A1 258/4885LMNA 3246/4885TSHR 800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.